ADCYAP1 and Parkinson disease: An antiapoptotic effect of PACAP involving an inhibition of caspase-3 activity has also been shown in cellular models of AD (Onoue et al., 2002) and PD (Wang et al., 2005) with Aβ- and rotenone-induced toxicity, respectively.